Clinical Trial

Chinese PD-SNCA Registry

Name: Chinese PD-SNCA Registry — clinical trial record (NCT03523052)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

The purpose of the Chinese PD-SNCA Registry(CPD-SNCAR) is to develop a database of patients of Parkinson's disease with a-synuclein (SNCA) gene variants in mainland China.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2018-05-01.

Trial Details

NCT Number	NCT03523052
Lead Sponsor	Xiangya Hospital of Central South University
Conditions	Parkinson Disease
Enrollment	3,000 participants
Start Date	2017-02-01
Primary Completion	2027-02-01 (estimated)
Study Completion	2027-02-01 (estimated)
Updated on ClinicalTrials.gov	2018-05-29